Source: Business Insider South Africa
Although side effects were less common in the J&J trial compared to other vaccines, some recipients experienced discomfort after their shots.
J&J COVID-19 Vaccine To Get Supply Boost As Manufacturing Partner Secures Key FDA Clearance
Source: Benzinga
Johnson & Johnson’s (NYSE: JNJ ) COVID-19 vaccine is expected to get a significant supply boost after manufacturing partner Catalent Inc (NYSE: CTLT ) secured a key U.S. regulator clearance, Bloomberg News reported on Tuesday. What Happened: A U.S. Food and Drug Administration’s emergency-use clearance received Tuesday will allow Catalent’s facility in Bloomington, Indiana, to manufacture and ship millions of doses helping boost the vaccination supply. White House Press Secretary Jen Psaki on Tuesday said the U.S. is allocating 27 million doses across all channels this week, of … Full story available on Benzinga.com
Asbestos-Laced Baby Powder Maker Johnson & Johnson’s Experimental COVID Injection Death List Begins: A 32 & A 35-Year-Old
Source: USSA News
As with the other manufacturers of experimental mRNA COVID injections, asbestos-laced baby powder maker Johnson & Johnson’s experimental COVID “one jab” injection is starting its death toll. Following their Johnson & Johnson jabs, a 25-year-old female and a 32-year-old male have lost their lives. Company That Knew Asbestos Was In Its Baby Powder Now Distributing […]
Former Johnson & Johnson Executive Joins Advisory Board at Maitri Health Technologies
Source: PR Newswire
Bridget Ross brings extensive experience in MedTech development and services; Joins advisory board of healthcare, logistics, capital markets and innovation leaders VANCOUVER, BC, March 23, 2021 /PRNewswire/ – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global…
Businessinsider.co.za | US officials worried Johnson & Johnson won’t deliver 20 million vaccines promised by end-March
Source: Business Insider South Africa
The doses are supposed to help Biden fulfill the goal of having vaccines available to all US adults by May 1.
More local firms to produce vaccines as demand soars
Source: Economic Times India
India’s pharma industry that primarily made drugs and injectables is vying to be the top supplier of Covid vaccines to the world. As many as half a dozen Indian companies have signed manufacturing deals with the developers of Covid vaccines. Pune’s Serum Institute of India is already one of the top suppliers globally.Apart from these six, Bharat Biotech is in talks with regulators in Latin American countries such as Brazil to supply the vaccine it has developed in India. Hyderabad-headquartered Bharat Biotech will supply 20 million doses of the Covaxin through the second and third quarters of 2021.81643336While Serum Institute manufactures the Oxford-AstraZeneca vaccine, most of the other deals for contract manufacturing have come from the Russian Development Investment Fund (RDIF) for the Russia-developed Sputnik V vaccine.Hyderabad-based Biological E has become eligible to receive funding under the India-US-Japan-Australia quadrilateral initiative to manufacture and supply Johnson & Johnson’s single-dose Covid vaccine to low- and middle-income countries.Serum Institute is the only one that has completed its trials and has its vaccine manufacturing plants approved by regulators in the UK, EU and Canada.
Biden administration not confident Johnson & Johnson will meet 20 million goal by end of month
Source: CNN
Officials in President Joe Biden’s administration are not confident that Johnson & Johnson will meet its self-imposed deadline to deliver 20 million coronavirus vaccines by the end of March, despite optimistic statements from the company.
Biden administration frets J&J may miss vaccine goal
Source: POLITICO
The full tranche of vaccine Johnson & Johnson committed in February to delivering may not be ready to ship until the second or third week of April.
You can get a free Krispy Kreme doughnut every day for the rest of 2021 – here’s how
Source: BGR
According to the latest data from the Bloomberg Vaccine Tracker , 127 million coronavirus vaccine doses have been administered in the United States to date. The country is averaging close to 2.5 million doses a day, and that number should continue to rise as eligibility expands leading up to May 1st, which is when President Biden says all American adults will be eligible. At this point, it’s hard to imagine that anyone needs an incentive to get vaccinated as soon as possible, but for those that do, Krispy Kreme is running a truly delicious promotion . Starting Monday, March 22nd, anyone who shows their COVID-19 Vaccination Record Card at a Krispy Kreme store will receive a free Original Glazed doughnut. Everyone who has received at least one dose of the Moderna or Pfizer vaccine or the single dose of the Johnson & Johnson vaccine should have received a card with their name, date of birth, and the date and location they got their shot. Present that and get a free doughnut. While a single free doughnut might have been incentive enough for some hungry customers, the promotion does not end after you show your COVID-19 Vaccination Record Card just once.
Pennsylvania: Entire School District Closed After More Than 40 Staffers Called In With “Vaccine Reactions”
Source: USSA News
More than 40 staffers in a Pennsylvania school district called in “sick” due to reactions to the COVID-19 mRNA gene therapies. Pennsylvania has been vaccinating teachers and school staff members with its allocation of the one-shot Johnson & Johnson gene therapy, labeled a vaccine. The Upper Perkiomen School District said late Thursday that dozens of staff […]
